BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2502567)

  • 21. Use of mupirocin ointment in the treatment of secondarily infected dermatoses.
    Breneman DL
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):886-92. PubMed ID: 2112167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-centre general practice trial comparing Fucidin Ointment and Fucidin Cream.
    Baldwin RJ; Cranfield R
    Br J Clin Pract; 1981 Apr; 35(4):157-60. PubMed ID: 7028066
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
    Vingsbo Lundberg C; Frimodt-Møller N
    Int J Antimicrob Agents; 2013 Sep; 42(3):272-5. PubMed ID: 23837927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative trial of fucidin ointment and fucidin cream in skin sepsis.
    Pakrooh H
    J Int Med Res; 1980; 8(6):425-9. PubMed ID: 7439520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1987 Jan; 19(1):1-5. PubMed ID: 3104272
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the efficacy and toxicity of local fusidic aid versus oral dicloxacillin in infections of the skin].
    Macotela-Ruiz E; Durán Bermúdez H; Kuri Con FJ; Arevalo López A; Villalobos Ibarra JL
    Med Cutan Ibero Lat Am; 1988; 16(2):171-3. PubMed ID: 3050336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
    McLinn S
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the role of mupirocin.
    Lamb YJ
    J Hosp Infect; 1991 Sep; 19 Suppl B():27-30. PubMed ID: 1684188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid')--a controlled trial.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1986 Mar; 17(3):365-72. PubMed ID: 3084442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical antibiotic treatment of impetigo with mupirocin.
    Eells LD; Mertz PM; Piovanetti Y; Pekoe GM; Eaglstein WH
    Arch Dermatol; 1986 Nov; 122(11):1273-6. PubMed ID: 3096221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Topical antibiotics and clinical use].
    Cesur S
    Mikrobiyol Bul; 2002; 36(3-4):353-61. PubMed ID: 12838671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.
    Moy JA; Caldwell-Brown D; Lin AN; Pappa KA; Carter DM
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):893-5. PubMed ID: 2112168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyogenic cutaneous infections in East African children treated with Fucidin ointment.
    Garborg O; Nyjordet R
    J Trop Pediatr Environ Child Health; 1971 Dec; 17(4):153-7. PubMed ID: 5212063
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical mupirocin versus topical neosporin in the treatment of cutaneous infections.
    Wilkinson RD; Carey WD
    Int J Dermatol; 1988 Sep; 27(7):514-5. PubMed ID: 2851560
    [No Abstract]   [Full Text] [Related]  

  • 35. Pseudomonic acid, a new antibiotic for topical therapy.
    Wuite J; Davies BI; Go MJ; Lambers JC; Jackson D; Mellows G; Tasker TC
    J Am Acad Dermatol; 1985 Jun; 12(6):1026-31. PubMed ID: 3924981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis.
    Luber H; Amornsiripanitch S; Lucky AW
    Arch Dermatol; 1988 Jun; 124(6):853-4. PubMed ID: 3132108
    [No Abstract]   [Full Text] [Related]  

  • 37. Interventions for impetigo.
    Koning S; Verhagen AP; van Suijlekom-Smit LW; Morris A; Butler CC; van der Wouden JC
    Cochrane Database Syst Rev; 2004; (2):CD003261. PubMed ID: 15106198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comment: topical mupirocin.
    Pappa KA
    Drug Intell Clin Pharm; 1987 May; 21(5):466. PubMed ID: 3107962
    [No Abstract]   [Full Text] [Related]  

  • 39. Mupirocin ointment indications.
    Hudson I
    Infect Control Hosp Epidemiol; 1990 Sep; 11(9):452. PubMed ID: 2121821
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical development of mupirocin.
    Pappa KA
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):873-9. PubMed ID: 2112164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.